ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SRCIOTA. The owner is based in ZHONGSHAN.

NO. 8, LANE 3, LIANWUZHENG ST., SHIMENLIANYU VILLAGE

CUIHENG VILLAGE, NANLANG ST.

ZHONGSHAN 528400 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SRCIOTA
SRCIOTA
Registered 2020

Trademark Classifications

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. have?

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. file in?

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD.'s most well-known trademarks?

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as SRCIOTA. These are among 1 currently registered trademark in the portfolio.

What is ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD.'s trademark registration success rate?

ZHONGSHAN XIANGSHUANG TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.